WHC is still in active development. Read this to understand our approach.
depiction of LDCYZAJDBXYCGN-UHFFFAOYSA-N.svg
tripsit

5-htp

Check on tripsit

psychonaut

5-Hydroxytryptophan

Check on psychonaut

isomerdesign

5-HTP

Check on isomerdesign

pubchem

5-Hydroxytryptophan

Check on pubchem

druglab

5-hydroxytryptophane

Check on druglab

drugmap

5-hydroxy-L-tryptoph...

Check on drugmap

wiki

5-Hydroxytryptophan

Check on wiki

Data

InChI: InChI=1S/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-2-1-7(14)4-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)

Synonyms: (+/-)-5-Hydroxytryptophan,(2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoicacid,CHEMBL350221,5-Hydroxytryptophan,FT-0627633,Tox21_500627,AKOS004119863,Oxitriptan [INN],Dl-oxitriptan,HY-B1716,Ro 3-5940 HCl,oxitriptan,C01017,bmse000457,UNII-9181P3OI6N,Oxitriptano,DTXSID50859863,4PQ,5-hydroxy-L-tryptophan,Levothym,SCHEMBL43243,5-Hydroxyl-L-tryptophan,DB-051092,5-hydroxytryptophan - 5-HTP,5-HYDROXY-L-TRYPTOPHAN [USP-RS],CCG-235444,HYDROXYTRYPTOPHAN [VANDF],DTXSID1025437,DL-5-HTP,5-Hydroxytryptophan L form,SDCCGSBI-0050608.P002,GTPL4671,(+-)-5-Hydroxytryptophan,FT-0620498,5-HYDROXYTRYPTOPHAN [MI],S(+)-1-alpha-Amino-5-hydroxyindole-3-propionic acid,CCG-204715,4350-09-8,Serotain,Quietim,5-Hydroxytryptophan, AldrichCPR,H-DL-Trp(5-OH)-OH,MFCD00064341,N88462,SCHEMBL43242,L-5-Htp,5-Hydroxy L-Tryptophan-[d4],OXITRIPTAN [WHO-DD],α-Carboxy-5-hydroxytryptamine,Triptene,Lopac-H-9772,Q-102914,SR-01000075584-1,5-hydroxy-L-tryptophane,5-hydroxytryptophan, dl-,Q27103541,Lopac0_000627,NCGC00091062-05,CHEBI:28171,H0531,NCGC00091062-07,5-22-14-00278 (Beilstein Handbook Reference),Oxitriptan 1,5htp,9181P3OI6N,NCGC00091062-06,HMS2231H15,(S)-2-Amino-3-(5-hydroxy-1H-indol-3-yl)propanoic Acid (5-Hydroxytryptophan),5 Hydroxytryptophan,Oxitriptan (5-Hydroxy-L-tryptophan),NSC92523,5-HYDROXYTRYPTOPHAN L-FORM [MI],s4769,5-Hydroxytryptophan L-form,HY-N0122,BRN 0088200,l-tryptophan,NCGC00091062-01,NCGC00015526-02,C1LJO185Q9,SMR000326745,Tryptophan, 5-hydroxy-, dl,D,L-5-hydroxytryptophan,CS-W019879,5-Hydroxy-L-tryptophan, United States Pharmacopeia (USP) Reference Standard,Oxitriptanum [INN-Latin],Levothym (TN),NCGC00091062-12,Q-200544,Tripten,FT-0620491,56H699,STK803137,5-hydroxytryptophan(5-HTP),MLS006011926,5-hydroxytryptophan,NCGC00091062-09,(2S)-2-amino-3-(5-hydroxyindol-3-yl)propanoic acid,(.+-.)-5-Hydroxytryptophan,AC-13632,EINECS 200-284-8,EU-0100627,Z2044741046,5-Hydroxytryptophan #,(S)-2-Amino-3-(5-hydroxy-1H-indol-3-yl)-propionic acid;C5-Hydroxy-L-tryptophan;5-HTP;Oxitriptan,VS-03256,DL-Hydroxytryptophan,N-ACETYLTRYPTOPHAN IMPURITY D [EP IMPURITY],OXITRIPTAN [MART.],FT-0620490,FT-0620484,Oxitriptano [INN-Spanish],SMR001230815,HMS3656M11,EN300-1720935,Serotonyl,H-Trp(5-OH)-OH,Pretonine,NCGC00015526-04,HSDB 4295,s2374,SY030569,SY048412,Tox21_111073,5-Hydroxytryptophan DL-form,MLS002153452,DL-Tryptophan, 5-hydroxy-,5-hydroxy tryptophan,AKOS016050369,L-5-Hydroxytryptophane,EINECS 224-411-1,BBL012270,H-L-Trp(5-OH)-OH,5HTP,NCGC00091062-03,A2320,L-2-Amino-3-(5-hydroxyindolyl)propionic acid,hydroxytryptophan,Tox21_201032,C00643,56-69-9,(S)-5-Hydroxytryptophan,2-Amino-3-(5-hydroxy-1H-indol-3-yl)propionic acid,Oxitriptanum,L-5-HTTP,BDBM50403163,H-8280,tryptophan,CS-0007832,EN300-244707,UNII-C1LJO185Q9,D07339,L-Tryptophan, 5-hydroxy-,BRN 0088199,CHEBI:17780,5-Hydroxy-DL-tryptophan,NCGC00091062-02,5-HYDROXY-TRYPTOPHAN,SCHEMBL19871232,Tript-OH,NCGC00261312-01,NSC-92523,Tryptophan, 5-hydroxy-, L-,2-Amino-3-(5-hydroxy-1H-indol-3-yl)propanoicacid,CCRIS 4418,USAF CB-96,AKOS003382640,NCGC00015526-01,Q238544,Levotinine,72572-98-6,MFCD00005651,NCGC00091062-08,DL-Pretonine,NCGC00091062-04,TRYPTOPHAN IMPURITY D [EP IMPURITY],HMS3884H15,5-hydroxytryptophan (5-HTP),H 9772,NSC 92523,DL-2-Amino-3-(5-hydroxyindolyl)propionic acid,CHEMBL162789,5-HTP,(2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid,DB02959,Oxitriptan (INN),HMS3261N16,dl-5-Hydroxytryptophane,NCGC00258585-01,Telesol,114-03-4,L-5-Hydroxytryptophan,Cincofarm,NCI-C56644,LP00627,AM20060629,Tryptophan, 5-hydroxy-,SR-01000003309-1,A826297,(S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid,CDAD59D9-D915-46DD-8029-48C808976B7C,5-Hydroxy-L-tryptophan, powder,2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid,CAS-4350-09-8,5-Hydroxytryptophane,SW219417-1,SR-01000075584,DTXCID005437,HMS3372G05,Tox21_111073_1,L-5-Hydroxytryptophan (L-5-HTP; Oxitriptan),AC-24420,SR-01000003309,WLN: T56 BMJ D1YZVQ GQ,AC-23979,2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoicacid,L-oxitriptan,AS-12269,HYDROXYTRYPTOPHAN [INCI],Oxyfan,5-hydroxyltryptophan,DL-5-Hydroxytryptophan,5-HYDROXYTRYPTOPHAN [HSDB],Tryptophan, 5-HTP

Market name: 5-htp


Estimated data

Solubility: -1.769 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 45.3% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.